139 related articles for article (PubMed ID: 32620821)
1. Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction.
Falcão F; Oliveira F; Cantarelli F; Cantarelli R; Brito Júnior P; Lemos H; Silva P; Camboim I; Freire MC; Carvalho O; Sobral Filho DC
Sci Rep; 2020 Jul; 10(1):11016. PubMed ID: 32620821
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen 125 predicts pulmonary congestion in patients with ST-segment elevation myocardial infarction.
Falcão FJA; Oliveira FRA; Cantarelli F; Cantarelli R; Brito-Júnior P; Lemos H; Silva P; Camboim I; Freire MC; Carvalho O; Sobral-Filho DC
Braz J Med Biol Res; 2019; 52(12):e9124. PubMed ID: 31826182
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Schmid H; Trenkwalder T; Mayr NP; Joner M; Kasel AM; Holdenrieder S; Nunez J; Sanchis J; Bodi V; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Am J Cardiol; 2018 Feb; 121(4):461-468. PubMed ID: 29306485
[TBL] [Abstract][Full Text] [Related]
4. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers enhance the long-term predictive ability of the KAMIR risk score in Chinese patients with ST-elevation myocardial infarction.
Wang JJ; Fan Y; Zhu Y; Zhang JD; Zhang SM; Wan ZF; Su HL; Jiang N
Chin Med J (Engl); 2019 Jan; 132(1):30-41. PubMed ID: 30628957
[TBL] [Abstract][Full Text] [Related]
6. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure.
Mansour IN; Napan S; Tarek Alahdab M; Stamos TD
Congest Heart Fail; 2010; 16(1):15-20. PubMed ID: 20078623
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
9. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigen 125 combined with N-terminal pro-B-type natriuretic peptide in the prediction of acute heart failure following ST-elevation myocardial infarction.
Xu K; Wu M; Huang M; Zhuo X; Weng Y; Chen X
Medicine (Baltimore); 2022 Dec; 101(48):e32129. PubMed ID: 36482545
[TBL] [Abstract][Full Text] [Related]
11. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock.
Sharma YP; Kanabar K; Santosh K; Kasinadhuni G; Krishnappa D
Indian Heart J; 2020; 72(4):302-305. PubMed ID: 32861389
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
[TBL] [Abstract][Full Text] [Related]
13. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
[TBL] [Abstract][Full Text] [Related]
14. The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction.
Celebi S; Celebi OO; Cetin S; Cetin HO; Tek M; Gokaslan S; Amasyali B; Berkalp B; Diker E; Aydogdu S
Arq Bras Cardiol; 2019 Dec; 113(6):1129-1137. PubMed ID: 31664316
[TBL] [Abstract][Full Text] [Related]
15. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
He PC; Duan CY; Liu YH; Wei XB; Lin SG
BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
19. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
20. Increased Serum CA125 and Brain-Derived Neurotrophic Factor (BDNF) Levels on Acute Myocardial Infarction: A Predictor for Acute Heart Failure.
Wu H; Cao G; Wang Y; Tian H; Du R
Med Sci Monit; 2019 Feb; 25():913-919. PubMed ID: 30706901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
